About this trial
Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.
Eligibility criteria
Qualifiers
Biological sex is female
Intelligence Quotient 70 or higher
Reading level 5th grade or higher
Able to speak and understand English
Disqualifiers
Uncorrectable auditory or visual deficits
Currently pregnant
MRI contraindication
Central nervous system disease
Trial design
Treatments tested in this trial
- Decision task
Treatment groups
7
Treatment groupsSee each treatment group below.